Texas Tech University Health Sciences Center
Odessa, Texas, 79763, United States
NCT Number: NCT01268111
Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vitamin D replacement improves insulin sensitivity. Serum Retinol Binding Protein 4 levels will also be measured to see if changes in insulin sensitivity are mediated by RBP4.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 1
Odessa, Texas, 79763, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ERgocaclciferol 50,000 units weekly for 8 weeks
matching placebo
Time frame: Baseline and at 8 weeks
Insulin stimulated glucose uptake will be measured by glucose clamp studies
Texas Tech University Health Sciences Center
Other
Effect of Vitamin D Supplementation on Insulin Sensitivity and Retinol-binding Protein 4 Levels in Subjects With Vitamin D Deficiency
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02169050
Avitaminosis, Body Weight
Chicago, Illinois, United States
View Trial DetailsNCT00851396
Avitaminosis, Body Weight
Birmingham, Alabama, United States
View Trial DetailsNCT04264897
Aging, Chronic Disease
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT05764200
Glucose Metabolism Disorders, Glucose Metabolism Disorders (Including Diabetes Mellitus)
Maastricht, Netherlands
View Trial Details